Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2018

Open Access 01-12-2018 | ASO Author Reflections

ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases

Authors: Nina R. Sluiter, MD, Jurriaan B. Tuynman, MD, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) improve survival of patients with colorectal peritoneal metastases (PM).1 Careful patient selection is pivotal because this treatment is associated with substantial morbidity, but current selection criteria fail to discriminate sufficiently between patients who will and those who will not benefit. Next to preoperative imaging, which has limited accuracy for detection of PM, selection is based largely on intraoperative assessment of the peritoneal cancer index (PCI).2 However, selection should ideally take place before surgery. …
Literature
1.
Mirnezami R, Mehta AM, Chandrakumaran K, et al. Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone. Br J Cancer. 2014;111:1500–8.CrossRefPubMedPubMedCentral
2.
Kwakman R, Schrama AM, van Olmen JP, et al. Clinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis. Ann Surg. 2016;263:1102–11.CrossRefPubMed
3.
Esquivel J. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection. J Gastrointest Oncol. 2016;7:72–8.CrossRefPubMedPubMedCentral
4.
Dube P, Sideris L, Law C, et al. Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms. Curr Oncol. 2015;22:e100–12.CrossRefPubMedPubMedCentral
5.
Sluiter NR, Rovers KP, Salhi Y, et al. Metachronous peritoneal metastases after adjuvant chemotherapy are associated with poor outcome after cytoreduction and HIPEC. Ann Surg Oncol. 2018;25:2347–56.CrossRefPubMedPubMedCentral
Metadata
Title
ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases
Authors
Nina R. Sluiter, MD
Jurriaan B. Tuynman, MD, PhD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6842-6

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue

ASO Author Reflections

ASO Author Reflections: Tegafur–Uracil in Advanced Oral Cancer

ASO Author Reflections

ASO Author Reflections: We Can Stomach It: Personalizing Medicine with EGD-Derived Gastric Cancer Organoids

ASO Author Reflections

ASO Author Reflections: Novel Robotic Training Curriculum Used in Complex Surgical Oncology

ASO Author Reflections

ASO Author Reflections: Improving Patient Selection for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy

ASO Author Reflections

ASO Author Reflections: Narrow-Band Imaging: A Novel Imaging Method in Minimally Invasive Surgery

ASO Author Reflections

ASO Author Reflections: Size of Tumor Volume in Glioblastoma Patients